Post-pandemic Era-Global Oncology Biosimilar Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Report ID: 256033 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Oncology Biosimilar Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Lung Cancer -Product Introduction and Major Manufacturers
      1.1.2 Colorectal Cancer -Product Introduction and Major Manufacturers
      1.1.3 Cervical Cancer -Product Introduction and Major Manufacturers
      1.1.4 Breast Cancer -Product Introduction and Major Manufacturers
      1.1.5 Kidney Cancer -Product Introduction and Major Manufacturers
      1.1.6 Stomach Cancer -Product Introduction and Major Manufacturers
      1.1.7 Brain Cancer -Product Introduction and Major Manufacturers
      1.1.8 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
    2.1 China Oncology Biosimilar Status and Prospect (2015-2026)
      2.1.1 China Oncology Biosimilar Market Size and Growth Rate (2015-2026)
      2.1.2 China Oncology Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.2 EU Oncology Biosimilar Status and Prospect (2015-2026)
      2.2.1 EU Oncology Biosimilar Market Size and Growth Rate (2015-2026)
      2.2.2 EU Oncology Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.3 USA Oncology Biosimilar Status and Prospect (2015-2026)
      2.3.1 USA Oncology Biosimilar Market Size and Growth Rate (2015-2026)
      2.3.2 USA Oncology Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.4 Japan Oncology Biosimilar Status and Prospect (2015-2026)
      2.4.1 Japan Oncology Biosimilar Market Size and Growth Rate (2015-2026)
      2.4.2 Japan Oncology Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.5 India Oncology Biosimilar Status and Prospect (2015-2026)
      2.5.1 India Oncology Biosimilar Market Size and Growth Rate (2015-2026)
      2.5.2 India Oncology Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.6 Southeast Asia Oncology Biosimilar Status and Prospect (2015-2026)
      2.6.1 Southeast Asia Oncology Biosimilar Market Size and Growth Rate (2015-2026)
      2.6.2 Southeast Asia Oncology Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.7 South America Oncology Biosimilar Status and Prospect (2015-2026)
      2.7.1 South America Oncology Biosimilar Market Size and Growth Rate (2015-2026)
      2.7.2 South America Oncology Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.8  Oncology Biosimilar Status and Prospect (2015-2026)
      2.8.1  Oncology Biosimilar Market Size and Growth Rate (2015-2026)
      2.8.2  Oncology Biosimilar Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Oncology Biosimilar Market Assessment by Segment
    3.1 Global Oncology Biosimilar Capacity and Growth Rate
    3.2 Global Oncology Biosimilar Sales by Type
    3.3 Global Oncology Biosimilar Sales Revenue by Type
    3.4 Global Oncology Biosimilar Consumption by Application
4 Global Oncology Biosimilar Market Assessment by Regions
    4.1 Global Oncology Biosimilar Production Analysis and Forecast by Regions (2015-2026)
    4.2 Global Oncology Biosimilar Sales Analysis and Forecast by Regions (2015-2026)
    4.3 Global Oncology Biosimilar Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
    5.1 Oncology Biosimilar Value Chain Analysis
      5.1.1 Upstream
      5.1.2 Downstream
    5.2 COVID-19 Impact on Oncology Biosimilar Industry
      5.2.1 Industrial Policy Issued Under the Epidemic Situation
    5.3 Cost-Under the Epidemic Situation
      5.3.1 Cost of Raw Material
    5.4 Channel Analysis
      5.4.1 Distribution Channel-Under the Epidemic Situation
      5.4.2 Distributors
6 Competitive Landscape
    6.1 Global Oncology Biosimilar Capacity Market Share of Manufacturers (2019-2020)
    6.2 Global Oncology Biosimilar Sales Market Share of Manufacturers (2019-2020)
    6.3 Global Oncology Biosimilar Sales Revenue Market Share of Manufacturers (2019-2020)

7 Oncology Biosimilar Competitive Analysis
     7.1 Biocon
        7.1.1 Biocon Company Profiles
        7.1.2 Biocon Product Introduction
        7.1.3 Biocon Oncology Biosimilar Production, Revenue (2015-2020)
        7.1.4 SWOT Analysis
     7.2 Celltrion Inc.
        7.2.1 Celltrion Inc. Company Profiles
        7.2.2 Celltrion Inc. Product Introduction
        7.2.3 Celltrion Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        7.2.4 SWOT Analysis
     7.3 Dr. Reddy's Laboratories
        7.3.1 Dr. Reddy's Laboratories Company Profiles
        7.3.2 Dr. Reddy's Laboratories Product Introduction
        7.3.3 Dr. Reddy's Laboratories Oncology Biosimilar Production, Revenue (2015-2020)
        7.3.4 SWOT Analysis
     7.4 Intas Pharmaceuticals Ltd.
        7.4.1 Intas Pharmaceuticals Ltd. Company Profiles
        7.4.2 Intas Pharmaceuticals Ltd. Product Introduction
        7.4.3 Intas Pharmaceuticals Ltd. Oncology Biosimilar Production, Revenue (2015-2020)
        7.4.4 SWOT Analysis
     7.5 STADA Arzneimittel AG
        7.5.1 STADA Arzneimittel AG Company Profiles
        7.5.2 STADA Arzneimittel AG Product Introduction
        7.5.3 STADA Arzneimittel AG Oncology Biosimilar Production, Revenue (2015-2020)
        7.5.4 SWOT Analysis
     7.6 Pfizer Inc.
        7.6.1 Pfizer Inc. Company Profiles
        7.6.2 Pfizer Inc. Product Introduction
        7.6.3 Pfizer Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        7.6.4 SWOT Analysis
     7.7 Apotex Inc.
        7.7.1 Apotex Inc. Company Profiles
        7.7.2 Apotex Inc. Product Introduction
        7.7.3 Apotex Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        7.7.4 SWOT Analysis
     7.8 Teva Pharmaceutical Industries Ltd.
        7.8.1 Teva Pharmaceutical Industries Ltd. Company Profiles
        7.8.2 Teva Pharmaceutical Industries Ltd. Product Introduction
        7.8.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Production, Revenue (2015-2020)
        7.8.4 SWOT Analysis
     7.9 Sandoz International GmbH
        7.9.1 Sandoz International GmbH Company Profiles
        7.9.2 Sandoz International GmbH Product Introduction
        7.9.3 Sandoz International GmbH Oncology Biosimilar Production, Revenue (2015-2020)
        7.9.4 SWOT Analysis
     7.10 BIOCAD
        7.10.1 BIOCAD Company Profiles
        7.10.2 BIOCAD Product Introduction
        7.10.3 BIOCAD Oncology Biosimilar Production, Revenue (2015-2020)
        7.10.4 SWOT Analysis
     7.11 Mylan
     7.12 F Hoffmann-La Roche
8 Conclusion


List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Oncology Biosimilar Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Oncology Biosimilar Sales (K Unit) by Type (2015-2026)
    Figure Global Oncology Biosimilar Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Oncology Biosimilar Sales Market Share (%) by Type (2019 -2020)
    Table Global Oncology Biosimilar Sales Value (Million USD) by Type (2015-2026)
    Figure Global Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Oncology Biosimilar Sales Value Market Share (%) by Type (2019-2020)
    Table Global Oncology Biosimilar Sales (K Unit) by Application (2015-2026)
    Figure China Oncology Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
    Table China Oncology Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure EU Oncology Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
    Table EU Oncology Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure North America Oncology Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
    Table North America Oncology Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Japan Oncology Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
    Table Japan Oncology Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure India Oncology Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
    Table India Oncology Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Southeast Asia Oncology Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
    Table Southeast Asia Oncology Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure South America Oncology Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
    Table South America Oncology Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Middle East and Africa Oncology Biosimilar Production Value (Million USD) and Growth Rate (2015-2026)
    Table Middle East and Africa Oncology Biosimilar Local Capacity, Import, Export and Local Consumption (2015-2020)
    Table Global Oncology Biosimilar Capacity (K Units) and Growth Rate (2015-2026)
    Figure Global Oncology Biosimilar Capacity (K Units) and Growth Rate (2015-2026)
    Table Global Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure Global Oncology Biosimilar Sales(Unit) and Growth Rate (2015-2026)
    Table Sales Market Share (%) by Type (2019-2026)
    Table Global Oncology Biosimilar Sales Revenue (Million USD) by Type (2015-2026)
    Figure Global Oncology Biosimilar Sales Revenue (Million USD) and Growth Rate (2015-2026)
    Table Sales Revenue Market Share (%) by Type (2019-2026)
    Table Global Oncology Biosimilar Consumption (Unit) by Application (2015-2026)
    Figure Global Oncology Biosimilar Consumption (Unit) and Growth Rate (2015-2026)
    Table Consumption Market Share (%) by Application (2019-2026)
    Table Global Oncology Biosimilar Production (K Unite) by Regions (2015-2020)
    Table Global Oncology Biosimilar CAGR (%) in term of Production and Market Share by Regions (2015-2026)
    Figure Global Oncology Biosimilar Production Share by Regions (2019-2020)
    Table Global Oncology Biosimilar Sales (K Unite) by Regions (2015-2020)
    Table Global Oncology Biosimilar CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
    Figure Global Oncology Biosimilar Sales Share by Regions (2019-2020)
    Table Global Oncology Biosimilar Sales Revenue (Million USD) by Regions (2015-2020)
    Table Global Oncology Biosimilar CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
    Figure Global Oncology Biosimilar Sales Revenue Share by Regions (2019-2020)
    Figure Value Chain Structure of Oncology Biosimilar
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Oncology Biosimilar
    Figure Cost Structure of Oncology Biosimilar in 2020
    Table Global Oncology Biosimilar Capacity Share of Manufacturers (2019-2020)
    Figure Global Oncology Biosimilar Capacity Share of Manufacturers (2019-2020)
    Table Global Oncology Biosimilar Sales Market Share of Manufacturers (2019-2020)
    Figure Global Oncology Biosimilar Sales Market Share of Manufacturers (2019-2020)
    Table Global Oncology Biosimilar Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Oncology Biosimilar Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Oncology Biosimilar Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table Biocon Profiles
    Table Biocon Oncology Biosimilar Product Introduction
    Table Biocon Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Biocon SWOT Analysis
    Table Celltrion Inc. Profiles
    Table Celltrion Inc. Oncology Biosimilar Product Introduction
    Table Celltrion Inc. Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Celltrion Inc. SWOT Analysis
    Table Dr. Reddy's Laboratories Profiles
    Table Dr. Reddy's Laboratories Oncology Biosimilar Product Introduction
    Table Dr. Reddy's Laboratories Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Dr. Reddy's Laboratories SWOT Analysis
    Table Intas Pharmaceuticals Ltd. Profiles
    Table Intas Pharmaceuticals Ltd. Oncology Biosimilar Product Introduction
    Table Intas Pharmaceuticals Ltd. Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Intas Pharmaceuticals Ltd. SWOT Analysis
    Table STADA Arzneimittel AG Profiles
    Table STADA Arzneimittel AG Oncology Biosimilar Product Introduction
    Table STADA Arzneimittel AG Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure STADA Arzneimittel AG SWOT Analysis
    Table Pfizer Inc. Profiles
    Table Pfizer Inc. Oncology Biosimilar Product Introduction
    Table Pfizer Inc. Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Pfizer Inc. SWOT Analysis
    Table Apotex Inc. Profiles
    Table Apotex Inc. Oncology Biosimilar Product Introduction
    Table Apotex Inc. Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Apotex Inc. SWOT Analysis
    Table Teva Pharmaceutical Industries Ltd. Profiles
    Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Product Introduction
    Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Teva Pharmaceutical Industries Ltd. SWOT Analysis
    Table Sandoz International GmbH Profiles
    Table Sandoz International GmbH Oncology Biosimilar Product Introduction
    Table Sandoz International GmbH Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Sandoz International GmbH SWOT Analysis
    Table BIOCAD Profiles
    Table BIOCAD Oncology Biosimilar Product Introduction
    Table BIOCAD Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure BIOCAD SWOT Analysis
    Table Mylan Profiles
    Table Mylan Oncology Biosimilar Product Introduction
    Table Mylan Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Mylan SWOT Analysis
    Table F Hoffmann-La Roche Profiles
    Table F Hoffmann-La Roche Oncology Biosimilar Product Introduction
    Table F Hoffmann-La Roche Oncology Biosimilar Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure F Hoffmann-La Roche SWOT Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Oncology Biosimilar Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Oncology Biosimilar Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Oncology Biosimilar Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports